Transition to a Product-Specific Direct Sales Model in the United States
First written in FY2016. 7 of 11 entries say "Restated". Latest entry: FY2026.
4 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In the US market, we directly sell our own branded products in both the cardiovascular and non-cardiovascular fields.」
We continued direct sales of our own branded products in both the cardiovascular and non-cardiovascular fields in the US, focusing on peripheral, cerebrovascular and abdominal applications in the non-cardiovascular field. - FY2021RestatedAnnual report
「While leveraging its existing direct-sales structure, the company will build marketing and sales functions that work closely with physicians, the end customers, to identify market trends more quickly, and will work to expand sales while also using web-based sales.」
The company continues its policy of expanding sales based on its U.S. direct-sales structure, using physician-focused sales and marketing and web-based sales. - FY2020RestatedAnnual report
「In the U.S. market, the company had previously sold its core PTCA guidewires through distributors, but has sold them directly to hospitals and other customers through its subsidiary ASAHI INTECC USA, INC. since July 2018. While leveraging its existing direct-sales structure, it will build a marketing and sales organization that works closely with physicians, the end customers, to identify market trends more quickly and will work to expand sales.」
The company continues its U.S. direct-sales structure for PTCA guidewires and its policy of promoting sales by working closely with physicians to identify market trends. - FY2019RestatedAnnual report
「In the U.S. market, the company had previously sold its core PTCA guidewires through distributors, but has sold them directly to hospitals and other customers through its subsidiary ASAHI INTECC USA, INC. since July 2018.」
The company continues to explain the shift to a U.S. direct-sales structure, including PTCA guidewires, and subsequent sales promotion. - FY2019-Q3RestatedAnnual report
「In the U.S. market, the company shifted to direct sales of PTCA guidewires from July 2018. From July through December 2018, the first six months of the consolidated fiscal year, there was a dual-distribution period during which the former distributor was permitted to sell in parallel with the Group, resulting in a temporary decline in Group sales. Since January 2019, when the Group began exclusive direct sales, recent sales have been strong.」
The company reconfirmed that, following the shift to direct sales of PTCA guidewires in the United States, it moved to an exclusive direct-sales structure from January 2019 and that recent sales have been strong. - FY2019-Q2Shift to exclusive direct sales after a dual-distribution periodAnnual report
「In the U.S. market, the company shifted to direct sales of PTCA guidewires from July 2018. From July through December 2018, the first six months of the consolidated fiscal year, there was a dual-distribution period during which the former distributor was permitted to sell in parallel with the Group, resulting in a temporary decline in Group sales. From January 2019, when the Group began exclusive direct sales, sales have been very strong.」
Direct sales of PTCA guidewires in the United States began in July 2018, but sales temporarily declined from July through December 2018 during the dual-distribution period with the former distributor. From January 2019 onward, the Group moved to an exclusive direct-sales structure, and recent sales have been strong, it explains. - FY2019-Q1RestatedAnnual report
「As a measure to achieve this, during the first three months of the current consolidated fiscal year, the company began direct sales of its core PTCA guidewires in the U.S. market.」
The company reconfirmed that beginning direct sales of its core PTCA guidewires in the U.S. market had been implemented. - FY2018RestatedAnnual report
「In the U.S. market, the company had previously sold its core PTCA guidewires through distributors, but decided to sell them directly through its subsidiary ASAHI INTECC USA, INC. from July 2018.」
The company confirmed its policy of shifting to direct sales in the United States, including PTCA guidewires, and stated that implementation would begin in July 2018. - FY2018-Q3RaisedAnnual report
「The company resolved to begin direct sales of its core PTCA guidewire products in the U.S. market from July 2018.」
Previously, the U.S. subsidiary directly sold products other than PTCA guidewires. The company resolved to shift PTCA guidewires to direct sales from July 2018 onward, thereby expanding the scope of direct sales. - FY2017RestatedAnnual report
「Since July 2015, product groups other than PTCA guidewires have fully shifted to a structure in which the consolidated subsidiary ASAHI INTECC USA, INC. sells directly to hospitals and other customers.」
The company continues to have its U.S. subsidiary sell product groups other than PTCA guidewires directly. - FY2016First statedAnnual report
「Since July 2015, product groups other than PTCA guidewires have fully shifted to a structure in which the consolidated subsidiary ASAHI INTECC USA, INC. sells directly to hospitals and other customers. The company will continue strengthening its marketing and sales functions and work to increase earnings.」
It states that product groups other than PTCA guidewires had fully shifted to direct sales to hospitals and other customers by the U.S. subsidiary.